Researchers at McGill University have identified a new cellular pathway that limits the growth and spread of brain tumors by controlling the recycling of cell surface receptor proteins. The study, which will be published January 14 in the Journal of…
Read More
Study identifies distinct sub-types of aggressive tumours to allow for targeted treatment
A new study led by clinician-scientists from the National Cancer Centre Singapore (NCCS), with collaborators from research institutions worldwide, has found that angiosarcomas have unique genomic and immune profiles which allow them to be classified into three different subtypes. With…
Read More
Drug target for aggressive breast cancer found
A team of British and American scientists have discovered a way to slow the growth of breast cancer stem cells in the lab. The study led by Dr. Bruno Simões and Professor Rob Clarke from The University of Manchester could…
Read More
Novel therapeutic approaches for aggressive bone cancer
Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study led by geneticist Erwin Wagner has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic and treatment strategies…
Read More
Study: The immune effects of seclidemstat in aggressive ovarian cancer striking young women
A drug known as SP-2577 could help enable the body’s own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Published today in the scientific…
Read More